Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel

Abstract Paclitaxel (PTX), especially albumin-bound PTX in clinical, has displayed significant inhibition of tumor growth in patients. But the systemic distribution and poor water solubility of PTX often lead to severe side effects, consequently limiting the anti-tumor efficacy. In this study, we de...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaoyu Pei, Feifei Luo, Jun Zhang, Wulian Chen, Chen Jiang, Jie Liu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/de33b223e6dd412ebdab1df4a675e07f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de33b223e6dd412ebdab1df4a675e07f
record_format dspace
spelling oai:doaj.org-article:de33b223e6dd412ebdab1df4a675e07f2021-12-02T12:31:46ZDehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel10.1038/s41598-017-01168-72045-2322https://doaj.org/article/de33b223e6dd412ebdab1df4a675e07f2017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01168-7https://doaj.org/toc/2045-2322Abstract Paclitaxel (PTX), especially albumin-bound PTX in clinical, has displayed significant inhibition of tumor growth in patients. But the systemic distribution and poor water solubility of PTX often lead to severe side effects, consequently limiting the anti-tumor efficacy. In this study, we developed a novel PTX-loaded polymeric micelle drug delivery system. These self-assembled polymeric micelles from core to outside consisted of poly L-phenylalanine (pPhe), DTSSP linked poly L-lysine (pLys), poly ethylene glycol (PEG) and dehydroascorbic acids (DHA). pPhe formed the hydrophobic core to encapsulate PTX; DTSSPs on pLys covalently cross-linked and formed disulfide bond to stabilize PTX from loss in blood circulation; PEG improved solubility to lower toxicity of PTX for its high hydrophilicity; DHA targeted tumors by specifically recognizing GLUT1 mainly expressed on tumor cells. Thus, PTX would be precisely released into tumor cells with high dose of glutathione to break disulfide bond. Moreover, these PTX-loaded polymer micelles significantly suppressed tumor cell viability, proliferation, and migration in vitro, and also greatly inhibited tumor growth and prolonged survival in tumor-bearing mice without detectable side effects. Therefore, the new drug delivery system could reduce severe side effects and enhance anti-tumor efficacy of PTX via peripheral stabilization, low toxicity and tumor targeting.Xiaoyu PeiFeifei LuoJun ZhangWulian ChenChen JiangJie LiuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiaoyu Pei
Feifei Luo
Jun Zhang
Wulian Chen
Chen Jiang
Jie Liu
Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel
description Abstract Paclitaxel (PTX), especially albumin-bound PTX in clinical, has displayed significant inhibition of tumor growth in patients. But the systemic distribution and poor water solubility of PTX often lead to severe side effects, consequently limiting the anti-tumor efficacy. In this study, we developed a novel PTX-loaded polymeric micelle drug delivery system. These self-assembled polymeric micelles from core to outside consisted of poly L-phenylalanine (pPhe), DTSSP linked poly L-lysine (pLys), poly ethylene glycol (PEG) and dehydroascorbic acids (DHA). pPhe formed the hydrophobic core to encapsulate PTX; DTSSPs on pLys covalently cross-linked and formed disulfide bond to stabilize PTX from loss in blood circulation; PEG improved solubility to lower toxicity of PTX for its high hydrophilicity; DHA targeted tumors by specifically recognizing GLUT1 mainly expressed on tumor cells. Thus, PTX would be precisely released into tumor cells with high dose of glutathione to break disulfide bond. Moreover, these PTX-loaded polymer micelles significantly suppressed tumor cell viability, proliferation, and migration in vitro, and also greatly inhibited tumor growth and prolonged survival in tumor-bearing mice without detectable side effects. Therefore, the new drug delivery system could reduce severe side effects and enhance anti-tumor efficacy of PTX via peripheral stabilization, low toxicity and tumor targeting.
format article
author Xiaoyu Pei
Feifei Luo
Jun Zhang
Wulian Chen
Chen Jiang
Jie Liu
author_facet Xiaoyu Pei
Feifei Luo
Jun Zhang
Wulian Chen
Chen Jiang
Jie Liu
author_sort Xiaoyu Pei
title Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel
title_short Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel
title_full Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel
title_fullStr Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel
title_full_unstemmed Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel
title_sort dehydroascorbic acids-modified polymer micelles target cancer cells to enhance anti-tumor efficacy of paclitaxel
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/de33b223e6dd412ebdab1df4a675e07f
work_keys_str_mv AT xiaoyupei dehydroascorbicacidsmodifiedpolymermicellestargetcancercellstoenhanceantitumorefficacyofpaclitaxel
AT feifeiluo dehydroascorbicacidsmodifiedpolymermicellestargetcancercellstoenhanceantitumorefficacyofpaclitaxel
AT junzhang dehydroascorbicacidsmodifiedpolymermicellestargetcancercellstoenhanceantitumorefficacyofpaclitaxel
AT wulianchen dehydroascorbicacidsmodifiedpolymermicellestargetcancercellstoenhanceantitumorefficacyofpaclitaxel
AT chenjiang dehydroascorbicacidsmodifiedpolymermicellestargetcancercellstoenhanceantitumorefficacyofpaclitaxel
AT jieliu dehydroascorbicacidsmodifiedpolymermicellestargetcancercellstoenhanceantitumorefficacyofpaclitaxel
_version_ 1718394309982552064